Corpus Intelligence IC Memo — EL PASO PSYCHIATRIC CENTER 2026-04-26 12:29 UTC
IC Memo — EL PASO PSYCHIATRIC CENTER
Investment Committee Memorandum | TX | 77 beds | Grade D | EBITDA uplift $1.4M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

EL PASO PSYCHIATRIC CENTER

CCN 454100 | EL PASO, TX | 77 beds | April 26, 2026
EBITDA BridgeData Room
D
Investability

1. Target Overview & Investment Thesis

EL PASO PSYCHIATRIC CENTER is a 77-bed community hospital in EL PASO, TX with $19.4M in net patient revenue and a -14.4% operating margin. The hospital serves a payer mix of 0.7% Medicare, 0.0% Medicaid, and 99.3% commercial.

Thesis: Turnaround. Our ML models identify $1.4M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -14.4% to -7.1% (+736bps).

Net Revenue HCRIS$19.4M
Current EBITDA COMPUTED$-2.8M
Operating Margin COMPUTED-14.4%
Occupancy HCRIS80.2%
Revenue / Bed COMPUTED$252K
Net-to-Gross HCRIS100.0%
Distress Probability MLnan%

2. Market Context & Competitive Position

583
TX Hospitals
-0.7%
State Median Margin
218
Comparable Hospitals

TX has 583 Medicare-certified hospitals with a median operating margin of -0.7%. The target's margin of -14.4% places it below the state median. Among 218 size-comparable peers (38-154 beds), the median margin is 1.6%. The target's below-peer margin suggests operational improvement opportunity.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (38-154), prioritizing same-state peers. 218 hospitals in the comp set.

HospitalStateBedsRevenueMargin
EL PASO PSYCHIATRIC CENTER (Target)TX77$19.4M-14.4%
THE HEART HOSPITAL BAYLOR PLANTX109$464.6M25.7%
COLLEGE STATION HOSPITALTX135$397.7M-0.9%
DECATUR COMMUNITY HOSPITALTX81$361.0M-15.5%
CHILDRENS MEDICAL CENTER OF PLTX72$336.7M20.9%
BAYLOR SW MEDICAL CENTER- WAXATX123$273.6M15.9%
BAYLOR HEART AND VASCULAR HOSPTX53$255.0M30.0%
TEXAS ORTHOPEDIC HOSPITATX42$237.8M46.3%
PRESBYTERIAN HOSP FLOWER MOUNDTX99$215.0M28.3%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $1.4M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$407K+210bp18mo
Cost to Collect4.5%2.5%$388K+200bp12mo
Denial Rate Reduction12.0%6.5%$384K+198bp12mo
A/R Days Reduction5200.0%3800.0%$236K+122bp9mo
Clean Claim Rate88.0%96.0%$12K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$407K
Cost to Collect
$388K
Denial Rate Reduction
$384K
A/R Days Reduction
$236K
Clean Claim Rate
$12K
Total EBITDA Uplift$1.4M
Current EBITDA$-2.8M
+ RCM Uplift+$1.4M
Pro Forma EBITDA$-1.4M
Current Margin-14.4%
Pro Forma Margin-7.1%
WC Released (1x)$744K

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$-4.3M$-4.2M0.00x-100.0%
Base (11x exit)10.0x11.0x$-4.3M$-6.0M0.00x-100.0%
Bull Case9.0x11.0x$-3.9M$-2.7M0.00x-100.0%
Bull (12x exit)9.0x12.0x$-3.9M$-4.0M0.00x-100.0%
Bear Case11.0x10.0x$-4.7M$-9.9M0.00x-100.0%
Bear (11x exit)11.0x11.0x$-4.7M$-12.4M0.00x-100.0%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
HighNegative operating marginRCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 218 hospitals with 38-154 beds
  • Same-state prioritization (n=219)
  • Comp margins: P25=-11.6% / P50=1.6% / P75=11.7%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.